Are today’s tools preparing you for tomorrow’s demands in STEM?
From AI-enabled chemistry discovery to biomedical evidence and biological insight, Elsevier fuels modern research that drives real impact—today and for generations to come.
Are you able to keep up with the accelerating pace of scientific discovery?
Reaxys and Embase are designed to work across the full research continuum: from chemistry discovery and retrosynthesis to biomedical literature and biological pathway intelligence. Whether you’re researching, teaching, or supporting campus innovation, we are here to partner with you to advance research and discovery at your institution.
Originally developed as the go-to solution for synthetic and organic chemistry, Reaxys has grown far beyond that origin. Today it is a comprehensive, AI-enabled solution supporting broader chemistry disciplines, empowering researchers, valid for accreditation and providing sustainable solutions for academic institutions.
Connected chemical, bioactivity, and toxicity evidence in one place, so researchers can evaluate novelty, feasibility, and safety earlier in the discovery process.
Natural language search, AI-generated summaries, and citation-traceable answers ensure every insight points back to its source.
Reaxys Retrosynthesis lets researchers review both published and AI-predicted synthesis routes in minutes, drawing on a vast base of experimentally validated reactions
The Conditions Navigator ranks evidence-based reaction conditions for each transformation, drawn directly from published data
Real-time commercial availability data helps teams prioritize the right candidates
AI-driven data extraction enables content coverage to grow continuously at scale, without the cost and bottlenecks of manual indexing.
AI built for modern discovery workflows following responsible AI development and with data privacy protected.
Systematic literature review and prior art: Embase and Reaxys
Comprehensive literature coverage is the foundation of sound science, whether confirming a compound's novelty, building a systematic review, or meeting regulatory requirements. Embase and Reaxys cover the full spectrum, from chemistry patents to global biomedical evidence, including clinical trials.
Embase is the biomedical database for systematic reviews, drug safety monitoring and evidence-based research and practice.
Comprehensive biomedical literature coverage available, including journals, conference abstracts, and ClinicalTrials.gov records, with daily updates of new content.
Recommended by the EMA, Cochrane, WHO, and a broad range of global regulatory and HTA bodies as a premier source for systematic reviews and pharmacovigilance.
The Emtree thesaurus, with its rich controlled vocabulary of preferred terms, synonyms, and drug, disease, and medical device subheadings, ensures researchers find everything relevant, even when different authors use different terminology.
Construct an advanced search with multiple query options in Embase: the PICO search form guides evidence-driven queries for systematic reviews; the PV Wizard supports high-recall adverse event searches; and dedicated medical device search forms simplify compliance with MDR and IVDR requirements.
Automatically convert your PubMed searches into Embase search syntax.
Embase AI adds a layer to an already powerful database. Researchers can query in natural language, surface connections across diverse sources, and move from a search question to actionable findings faster — without sacrificing the rigor and recall that systematic literature review demands.
Download more information
Still working harder than you need to?
Every institution is different. Tell us what’s holding your research back and together we can uncover how Reaxys and Embase can help.